These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 38659273)

  • 1. Heart failure: the grim reaper of the cardio-renal-metabolic triad.
    Österman J; Al-Sodany E; Haugen Löfman I; Barany P; Evans M
    ESC Heart Fail; 2024 Aug; 11(4):2334-2343. PubMed ID: 38659273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.
    Fu EL; Clase CM; Evans M; Lindholm B; Rotmans JI; Dekker FW; van Diepen M; Carrero JJ
    Am J Kidney Dis; 2021 May; 77(5):719-729.e1. PubMed ID: 33246024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimorbidity due to diabetes mellitus and chronic kidney disease and outcomes in chronic heart failure.
    Ekundayo OJ; Muchimba M; Aban IB; Ritchie C; Campbell RC; Ahmed A
    Am J Cardiol; 2009 Jan; 103(1):88-92. PubMed ID: 19101236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk trajectory of different cardiovascular morbidities associated with chronic kidney disease among patients with newly diagnosed diabetes mellitus: a propensity score-matched cohort analysis.
    Chao CT; Lee SY; Wang J; Chien KL; Hung KY
    Cardiovasc Diabetol; 2021 Apr; 20(1):86. PubMed ID: 33894776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic kidney disease and diabetes associated with long-term outcomes in patients receiving percutaneous coronary intervention.
    Lin MJ; Lee J; Chen CY; Huang CC; Wu HP
    BMC Cardiovasc Disord; 2017 Sep; 17(1):242. PubMed ID: 28893175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examining the impact of renal dysfunction and diabetes on post-myocardial infarction mortality: insights from a comprehensive retrospective cohort study across different age groups.
    Asser P; Fischer K; Ainla T; Marandi T; Blöndal M; Saar A; Eha J
    Scand Cardiovasc J; 2024 Dec; 58(1):2395875. PubMed ID: 39205475
    [No Abstract]   [Full Text] [Related]  

  • 7. Heart Failure Increases the Risk of Adverse Renal Outcomes in Patients With Normal Kidney Function.
    George LK; Koshy SKG; Molnar MZ; Thomas F; Lu JL; Kalantar-Zadeh K; Kovesdy CP
    Circ Heart Fail; 2017 Aug; 10(8):. PubMed ID: 28765150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart Failure in Patients with Diabetes and Chronic Kidney Disease: Challenges and Opportunities.
    Vijay K; Neuen BL; Lerma EV
    Cardiorenal Med; 2022; 12(1):1-10. PubMed ID: 34802000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of diabetes on clinical outcome of patients with heart failure undergoing ICD and CRT procedures: results from the German Device Registry.
    Kaya E; Senges J; Hochadel M; Eckardt L; Andresen D; Ince H; Spitzer SG; Kleemann T; Maier SSK; Jung W; Stellbrink C; Rassaf T; Wakili R
    ESC Heart Fail; 2020 Jun; 7(3):984-995. PubMed ID: 32068978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between β-Blocker Use and Mortality/Morbidity in Patients With Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction and Advanced Chronic Kidney Disease.
    Fu EL; Uijl A; Dekker FW; Lund LH; Savarese G; Carrero JJ
    Circ Heart Fail; 2020 Nov; 13(11):e007180. PubMed ID: 33070637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction.
    Löfman I; Szummer K; Dahlström U; Jernberg T; Lund LH
    Eur J Heart Fail; 2017 Dec; 19(12):1606-1614. PubMed ID: 28371075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absolute Rates of Heart Failure, Coronary Heart Disease, and Stroke in Chronic Kidney Disease: An Analysis of 3 Community-Based Cohort Studies.
    Bansal N; Katz R; Robinson-Cohen C; Odden MC; Dalrymple L; Shlipak MG; Sarnak MJ; Siscovick DS; Zelnick L; Psaty BM; Kestenbaum B; Correa A; Afkarian M; Young B; de Boer IH
    JAMA Cardiol; 2017 Mar; 2(3):314-318. PubMed ID: 28002548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of clinical outcomes in heart failure patients with and without advanced chronic kidney disease.
    Zahir Anjum D; Bonde AN; Fosbol E; Hartwell Garred C; Gislason G; Elmegaard M; Knigge P; Torp-Pedersen C; Andersson C; Pfeffer MA; Jhund PS; McMurray JJV; Petrie MC; Kober L; Schou M
    ESC Heart Fail; 2024 Oct; 11(5):3406-3415. PubMed ID: 38978335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Potassium and Risk of Death or Kidney Replacement Therapy in Older People With CKD Stages 4-5: Eight-Year Follow-up.
    de Rooij ENM; de Fijter JW; Le Cessie S; Hoorn EJ; Jager KJ; Chesnaye NC; Evans M; Windahl K; Caskey FJ; Torino C; Szymczak M; Drechsler C; Wanner C; Dekker FW; Hoogeveen EK;
    Am J Kidney Dis; 2023 Sep; 82(3):257-266.e1. PubMed ID: 37182596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.
    Jin Q; Luk AO; Lau ESH; Tam CHT; Ozaki R; Lim CKP; Wu H; Jiang G; Chow EYK; Ng JK; Kong APS; Fan B; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Huang Y; Lan HY; Szeto CC; So WY; Chan JCN; Ma RCW;
    Am J Kidney Dis; 2022 Aug; 80(2):196-206.e1. PubMed ID: 34999159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of diabetes mellitus in patients with heart failure and chronic kidney disease: a propensity-matched study of multimorbidity in chronic heart failure.
    Ritchie C; Ekundayo OJ; Muchimba M; Campbell RC; Frank SJ; Liu B; Aban IB; Ahmed A
    Int J Cardiol; 2009 May; 134(3):330-5. PubMed ID: 19178965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Cardio-Renal-Metabolic Comorbidities on Cardiovascular Outcomes and Mortality in Type 2 Diabetes Mellitus.
    Cherney DZI; Repetto E; Wheeler DC; Arnold SV; MacLachlan S; Hunt PR; Chen H; Vora J; Kosiborod M
    Am J Nephrol; 2020; 51(1):74-82. PubMed ID: 31812955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics.
    Htoo PT; Tesfaye H; Schneeweiss S; Wexler DJ; Everett BM; Glynn RJ; Kim SC; Najafzadeh M; Koeneman L; Farsani SF; Déruaz-Luyet A; Paik JM; Patorno E
    JAMA Netw Open; 2022 Oct; 5(10):e2237606. PubMed ID: 36264574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of mortality in heart failure with reduced ejection fraction: interaction between diabetes mellitus and impaired renal function.
    Yang Y; Huang Z; Wu B; Lu J; Xiu J; Tu J; Chen S; Pan Y; Bao K; Wang J; Chen W; Liu J; Liu Y; Chen S; Chen K; Chen L
    Int Urol Nephrol; 2023 Sep; 55(9):2285-2293. PubMed ID: 36867374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Separate and joint effects of diabetes mellitus and chronic kidney disease on the risk of acute coronary syndrome: a population-based cohort study.
    Chang YT; Liu CC; Tsai LM; Li CY; Sung JM
    Medicine (Baltimore); 2014 Dec; 93(28):e261. PubMed ID: 25526451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.